I have an acute myocardial infarction: Open my coronary artery, stent it and keep full flow!

European Heart Journal

Volumn 23, Issue 12, 2002, Pages 913-916

  Aschermann, M ^a   Widimsky P ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; CARDIOLOGY; CORONARY ARTERY DILATATION; CORONARY STENT; EDITORIAL; HUMAN; INTERVENTIONAL RADIOLOGY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT PLANNING;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ARTERIES; BLOOD FLOW VELOCITY; BLOOD VESSEL PROSTHESIS IMPLANTATION; CORONARY VESSELS; FIBRINOLYTIC AGENTS; HUMANS; MYOCARDIAL INFARCTION; STENTS;

EID: 0036623639     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.2001.3127     Document Type: Editorial

References (26)

1. Li RH, Herrmann HC. Facilitated percutaneous coronary intervention: A novel concept in expediting and improving acute myocardial infarction care. Am Heart J 2000; 140: S125-35.
2. Weaver WD, Simes RJ, Betriu A et al. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review. JAMA 1997; 278: 2093-8.
3. Gibson CM, Cannon CHP, Murphy SA et al. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation 2000; 101: 125-30.
4. Tan WA, Moliterno D. TIMI flow and surrogate end points: What you see is not always what you get. Am Heart J 1998; 136: 570-3.
5. Armstrong PW, Collen D. Fibrinolysis for acute myocardial infarction. Current sattus and new horizons for pharmacological reperfusion, Part 1. Circulation 2001; 103: 2862-6.
6. Armstrong PW, Collen D. Fibrinolysis for acute myocardial infarction. Current status and new horizons for pharmacological reperfusion, Part 2. Circulation 2001; 103: 2987-92.
7. Gibson CM. Primary angioplasty compared to thrombolysis: New issues in the era of glycoprotein IIb/IIIa inhibition and intracoronary stenting. Ann Int Med 1999; 130: 841-7.
8. Antman EM, Giugliano RP, Gibson CM et al. Abciximab facilitates the rate and extent of thrombolysis. Results of the Thrombolysis in Myocardial Infarction (TIMI) 14 Trial. Circulation 1999; 99: 2720-32.
9. Montalescot G, Barragan P, Wittenberg O et al. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. N Engl J Med 2001; 344: 1895-1903.
10. Brodie BR, Stuckey TD, Hansen Ch, Muncy D. Benefit of coronary reperfusion before intervention on outcomes after primary angioplasty for acute myocardial infarction. Am J Cardiol 2000; 85: 13-8.
11. Ross AM, Coyne KS, Reiner JS et al. A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: The PACT trial. PACT investigators. Plasminogen-activator Angioplasty Compatibility Trial. J Am Coll Cardiol 1999; 34: 1954-62.
12. The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993; 329: 673-82.
13. Fibrinolytic Therapy Trialists (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of early mortality and major morbidity results from all randomized trials of more than 1000 patients. Lancet 1994; 343: 311-22.
14. The Global Use of Strategy To Open Occluded Coronary Artery (GUSTO III) Investigators: A comparison of reteplase with alteplase for acute myocardial infarction. N Engl J Med 1997; 337: 1118-23.
15. Hearse DJ. Ischaemia, reperfusion and cardioprotection: Successes and failures in the journey from molecule to man. Eur Heart J Supplements 2001; 3 (Suppl C): C11-C21.
16. Brener SJ, Vrobel TR, Lopez JF et al. INTRO AMI: Marked enhancement of arterial patency with eptifibatide and low dose t-PA in acute myocardial infarction (Abstr). Circulation 1999; 100 (Suppl): 1-649.
17. The SPEED Group (Strategies for the Patency Enhancement in the Emergency Department). Randomized trial of abciximab with and without low-dose reteplase for acute myocardial infarction. Circulation 2000; 101: 2788-94.
18. Marwick TH, Brunken R, Meland N et al. Accuracy and feasibility of contrast echocardiography for detection of perfusion defects in routine practice: Comparison with wall motion and technetium-99m sestamibi single photon emission computed tomography: The Nycomed NC 100100 Investigators. J Am Coll Cardiol 1998; 32: 1260-9.
19. de Lemos JA, Antman EM, Gibson CM et al. Abciximab improves both epicardial flow and myocardial reperfusion in ST-elevation myocardial infarction. Observations from TIMI 14 trial. Circulation 2000; 101: 239-43.
20. The InTIME Investigators. Intravenous NPA for the treatment of infarcting myocardium early; InTIME, a double-blind comparison of single bolus lanoteplase vs accelerated alteplase for the treatment of patients with acute myocardial infarction. Eur Heart J 2000; 21: 2005-13.
21. Antman EM, Cooper HA, Gibson CM et al. Determinants of improvement in epicardial flow and myocardial perfusion for ST elevation myocardial infarction. Insights from TIMI 14 and InTIME-II. Eur Heart J 2002; 23: 928-33.
22. The GUSTO V Investigators. Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: GUSTO V randomized trial. Lancet 2001; 357: 1905-14.
23. The Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 Investigators. Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: The ASSENT-3 randomized trial in acute myocardial infarction. Lancet 2001; 358: 605-13.
24. Alonso A. Improved reperfusion and clinical outcome with enoxaparin as an adjunct to streptokinase thrombolysis in acute myocardial infarction. Presented at 50th Annual Scientific Session of the American College of Cardiology, Orlando, FL, March 2001.
25. Vermeer F, Oude Ophius AJ, Van den Berg EJ et al. Prospective randomized comparison between thrombolytics, rescue PTCA and primary PTCA in patients with extensive myocardial infarction admitted to the hospital without PTCA facilities: A safety and feasibility study. Heart 1999; 82: 426-31.
26. Widimský P, Groch L, Želízko M, Aschermann M, Bednář F, Suryapranata H and the PRAGUE Study Group. Multicenter randomized trial comparing transport to primary angioplasty vs. Immediate thrombolysis vs. Combined strategy for patients with acute myocardial infarction presenting to a community hospital without catheterization laboratory. Eur Heart J 2000; 21: 823-31.